Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Looneytuneson Dec 16, 2019 3:03am
145 Views
Post# 30458105

RE:RE:RE:RE:RE:Speculation

RE:RE:RE:RE:RE:SpeculationYes, and it is pure speculation; personally I'd hope for interim funding through to relisting to be provided by a loan, hopefully with a deferred repayment schedule to kick in on commercialisation but thats probably too much to hope for. I'd hope that the BODs aim would be to minimise the shares in circulation so as to maximise returns once we are able to start selling the CS, and once the market catches on to the magnitude of the impact that the CSS can have on their healthcare services.
Bullboard Posts